PF-05241328 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective inhibitor of specific enzymatic pathways that are often dysregulated in cancer cells. By targeting these pathways, the compound aims to inhibit tumor growth and proliferation, making it a candidate for cancer treatment. Its application is particularly relevant in research focused on understanding and disrupting the molecular mechanisms that drive cancer progression. Studies involving this compound are often conducted in preclinical settings to evaluate its efficacy, safety, and potential for further development as an anticancer agent.